New and Emerging Drug Classes That Will Outlast the Pandemic
https://www.biospace.com/article/-new-and-emerging-drug-classes-that-will-outlast-the-pandemic/
With companies like Cidara and OncoSec working to develop injectable vaccines and therapeutics for viral infections, someone needs to tackle the global crisis caused by bacterial infections. Enter Recce Pharmaceuticals Ltd, a biotech from down-under aiming to drive superbugs back under with synthetic polymer-based anti-infectives.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.010(3.33%) |
Mkt cap ! $89.39M | |||
| Open | High | Low | Value | Volume |
| 31.0¢ | 32.0¢ | 30.0¢ | $25.76K | 82.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13550 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 18938 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |